[{"uuid": "c56f10d6-6386-381f-b2c9-22c07b97dc10", "title": "Bike Locks Market Soars: U-Locks and Chain Locks Lead the Charge to $913.9 Million by 2030 | Valuates Reports", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/bike-locks-market-soars-u-150100297.html", "providerPublishTime": 1737471660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/9J_SnayryGSvKSGAAw._dw--~B/aD04Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/ef6f54d92729337f45c428989e3002da", "width": 400, "height": 82, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Ektfp51oJn2zqr4h.yDK5g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/ef6f54d92729337f45c428989e3002da", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "347e82c0-6100-336f-b7a9-085ea4331d09", "title": "Jim Cramer on\u00a0Arbutus Biopharma Corporation (ABUS): \u2018It Loses Money\u2019", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/jim-cramer-arbutus-biopharma-corporation-162243863.html", "providerPublishTime": 1737044563, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/8w93.VL1.albRX9jvG6aRQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4ba25b092a719fac7088939b62bcdbf1", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/RThKbpTeyCoaludA31brMw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4ba25b092a719fac7088939b62bcdbf1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABUS"]}, {"uuid": "eb69245d-1dca-3fbf-bf14-4be787c41a4a", "title": "Kymera Therapeutics (KYMR) Moves 7.8% Higher: Will This Strength Last?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/kymera-therapeutics-kymr-moves-7-143800359.html", "providerPublishTime": 1736951880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RZyMclhsK95NJkDMEE8f7A--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ad8d4e9642c3f390063ffee96cd8a696", "width": 900, "height": 900, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vn0G8sRceUlk1sILi9fmVw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/ad8d4e9642c3f390063ffee96cd8a696", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["KYMR", "ABUS"]}, {"uuid": "ff16b64e-5c95-328f-950e-2b3298f3fe8c", "title": "Electric Overhead Traveling (EOT) Cranes Market Size Worth $3.29 Billion, Globally, by 2031 Growing at 6.3% CAGR | Exclusive Report by The Insight Partners", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/electric-overhead-traveling-eot-cranes-132600462.html", "providerPublishTime": 1736774760, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KRWkrYJTwnmpscAajDHqWA--~B/aD0zMDA7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/30cfe6e5f5c1fc4be5c45fd2f8d5c6ab", "width": 300, "height": 300, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/FZDclT8eNm3OAXeIZxOvRA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/30cfe6e5f5c1fc4be5c45fd2f8d5c6ab", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "835c8c87-e10f-39e9-983b-ee741583dfe2", "title": "Arbutus Provides 2025 Corporate and Financial Update", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/arbutus-provides-2025-corporate-financial-123000233.html", "providerPublishTime": 1736771400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ugsVuQPbna0Jy3rReuGtvA--~B/aD0yNDg7dz01ODg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c931bbf097d2d858649792a4b9c1aa6a", "width": 588, "height": 248, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/mZ5VzXxxczvD.HcR0cBGDw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c931bbf097d2d858649792a4b9c1aa6a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABUS"]}, {"uuid": "f70da41a-cf22-3771-afce-c559cb4d5ea7", "title": "Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/arbutus-biopharma-abus-reports-q3-134507550.html", "providerPublishTime": 1730900707, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/132juehTNIyEUn7pK7.GPA--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619", "width": 900, "height": 506, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/twDpSkUZEyzUBc0qEMHAqw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABUS", "SPRO"]}, {"uuid": "d65e4013-efeb-3730-a92c-10df85475e23", "title": "\u2018Every Valley\u2019 Review: Handel\u2019s \u2018Messiah\u2019 in the Making", "publisher": "The Wall Street Journal", "link": "https://finance.yahoo.com/m/d65e4013-efeb-3730-a92c-10df85475e23/%E2%80%98every-valley%E2%80%99-review%3A.html", "providerPublishTime": 1734713880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Fwf5HL4GsEGPbDfR3MJBPg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 1200, "height": 630, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/zIJaagDuCJitt1Cvcwyc7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "a5af0860-df24-358d-bc33-08ef199895fc", "title": "Arbutus Biopharma Corp (ABUS) Q3 2024 Earnings Call Highlights: Promising Clinical Trials and ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/arbutus-biopharma-corp-abus-q3-071214125.html", "providerPublishTime": 1730963534, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/08mFns87fNfts8mmcENZbw--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/5f525422d6ab6794feeb427de1e1e91e", "width": 500, "height": 500, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/al8.5pPXBB9RMztY0tfA0w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/5f525422d6ab6794feeb427de1e1e91e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABUS"]}, {"uuid": "ad2085af-77b7-3bcb-9226-5299490d6ae7", "title": "Here\u2019s Why Arbutus (ABUS) Surged in Q3", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-arbutus-abus-surged-q3-132023599.html", "providerPublishTime": 1733491223, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ctjSs.uONjwp64QYgJbnuQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a81c7d302480ac96b05b0c658d49dad5", "width": 768, "height": 430, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/2VrVaRaVsJTJPI3.JEWdPg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/a81c7d302480ac96b05b0c658d49dad5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABUS"]}, {"uuid": "91233628-c435-322b-883a-63ff255ee74f", "title": "LCA Doubles Down on Exposing Animal Abuse at Italian Pig Farms, Files Legal Complaint, Addresses Industry Rebuttals", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/lca-doubles-down-exposing-animal-180500465.html", "providerPublishTime": 1734458700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/7dLAFysc3Zdu6rNwy3wkYg--~B/aD0xODI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6b26306f97c37fd76f190230df5fbb29", "width": 400, "height": 182, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/r_l0zqEiCSnCxDvFYp5M7w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/6b26306f97c37fd76f190230df5fbb29", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "a795b8d6-6d49-3e09-b0e5-b0ec72a0d1bb", "title": "Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/whitefort-capital-sends-letter-arbutus-130000141.html", "providerPublishTime": 1733230800, "type": "STORY", "relatedTickers": ["ABUS"]}, {"uuid": "9354424f-e6ce-330c-bf85-4a5546bb1716", "title": "Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/arbutus-barinthus-bio-announce-data-160100000.html", "providerPublishTime": 1731686460, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ugsVuQPbna0Jy3rReuGtvA--~B/aD0yNDg7dz01ODg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c931bbf097d2d858649792a4b9c1aa6a", "width": 588, "height": 248, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/mZ5VzXxxczvD.HcR0cBGDw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c931bbf097d2d858649792a4b9c1aa6a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABUS"]}]